SBC Medical Group Holdings Incorporated is a forward-thinking leader in the healthcare industry, dedicated to developing cutting-edge medical technologies and integrated solutions to enhance patient care. Focusing on advanced diagnostic tools and disease management systems, the company leverages innovative research to improve treatment effectiveness and health outcomes. With a steadfast commitment to quality and continuous innovation, SBC is strategically positioned to address significant healthcare challenges and foster sustainable growth, ultimately delivering long-term value to its investors and stakeholders.
| Revenue (TTM) | $169.34M |
| Gross Profit (TTM) | $119.90M |
| EBITDA | $63.73M |
| Operating Margin | 41.10% |
| Return on Equity | 16.50% |
| Return on Assets | 11.30% |
| Revenue/Share (TTM) | $1.65 |
| Book Value | $2.49 |
| Price-to-Book | — |
| Price-to-Sales (TTM) | — |
| EV/Revenue | - |
| EV/EBITDA | — |
| Quarterly Earnings Growth (YoY) | -47.10% |
| Quarterly Revenue Growth (YoY) | -9.00% |
| Shares Outstanding | 0 |
| Float | $18.11M |
| % Insiders | 0.00% |
| % Institutions | 0.00% |
Volatility is currently expanding
Tiblio connects your broker and runs your put-and-call-writing strategy for you — on SBCWW and any ticker you trade — then tracks every position and per-strategy win rate.